Newsletter | March 15, 2026

03.15.26 -- U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact

FEATURED EDITORIAL

U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact

Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.

9 Pharma Trends To Watch In 2026

What does 2026 ultimately hold for the industry? To explore that question, Lawrence Blatt, CEO of Aligos Therapeutics, sat down with me to share his perspective on the trends shaping the year ahead.

Process Engineering's Key Role In Sterile Injectable Facility Design

Quality requirements for parenteral drugs complicate facility design like few other regulated products. If you're developing injectables, be aware of these key issues.

INDUSTRY INSIGHTS

Patient-Centric Formulations In Pediatric Adherence

Aseptic Blow-Fill-Seal: A Sustainable Process For Packaging Pharma Liquids

The Transformational Impact Of A Digital Backbone

The Importance Of Container Closure Integrity (CCI) Feasibility Testing

Lung Cancer Treatment By Inhaled Formulations

Reshaping Roles In Batch Release: The Agentic AI Impact On Teams

Practical USP <1665>/<665> Guide To E&L Risk Assessment

GMP Calibration Management

Automating Visual Inspection Qualification

Raise Your Standards With Downflow Booth Airflow Containment

Enhancing Process Development With Viral Clearance

Overcome Common Pre-Filled Syringe Challenges Through Partnership

Improved Viable Particle Discrimination With Real-Time Particle Counter

How To Get Products To Patients Faster With A Connected QMS

How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions

Scaling Manufacturing Flexibility For Fill-Finish Commercial Success

Multi-Purpose Laboratory Mixers

Little Patients, Big Challenges: Developing Pediatric Formulations

Part II: Defining The Dye Ingress Operating Window

Choosing The Right PCD Configuration For Reliable Sterility Assurance

Multifactorial Disease Models: De-Risking Topical Formulation Development

Can Your Environmental Monitoring Process Pass Regulatory Scrutiny?

Advancing Drug Development Through Expertise In Energetic Chemistry

Utilizing Small-Scale Downstream Studies Across Biologics Manufacturing

A Patented Process For Intermediates Useful For Upadacitinib

Increasing Delivery System Flexibility Through Solvent-Based Processing

How Do We Reduce Your Environmental Cost Of Ownership (ECO)?

Maintaining Sterility Through Precise Component Design And Manufacture

Smart Manufacturing: A Strategic Imperative For Pharma's Future

Leveraging Autoinjector Innovation To De-Risk Biosimilar Development

Effect Of X-Ray Inspection On Pharmaceutical Products

Nitrosamines: Assessing The Risk To Pharma Products

The Hidden Costs Of Equipment Storage: What You're Really Paying For

Solve ATMP Aseptic Filling Challenges With Gloveless Isolators

The Way Forward: Supply Chain Solutions

AI At The Crossroads Of Regulation And Innovation

Advancing Drug Development Using In Silico Modeling

Lessons From FDA 483s And Warning Letters: Cleanroom Compliance

An Industry Approach To Adsorb Lipids Onto Powder Substrates

Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery

Zero-Stress Low Volume Aseptic Filling For Solids And Liquids

Connect With Pharmaceutical Online: